The Patent Finder

Theragen Etex Co., Ltd.

Also on record
Records under this name other than patents Theragen Etex Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Theragen Etex Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,427,547Edaravone Prodrug Compound and Pharmaceutical Use Thereof in Treatment or Alleviation of Neurodegenerative or Motor Neuron Disease
Lapsed on the fee record
Ended Aug 30, 2026 · High confidence
Lapsed on the fee recordEnded Aug 30, 2026High confidence
US 8,450,274DKK2 protein and use thereof
Formerly held
Lapsed on the fee record
Ended May 28, 2025 · USPTO record
Lapsed on the fee recordEnded May 28, 2025USPTO record
US 8,067,387Method for Stimulating Angiogenesis Using DKK2 and Composition Comprising the Same
Formerly held
Lapsed on the fee record
Ended Nov 29, 2023 · High confidence
Lapsed on the fee recordEnded Nov 29, 2023High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited